Survival of Classic Kaposi's Sarcoma and Risk of Second Cancer
Author Information
Author(s): S Franceschi, S Arniani, D Balzi, M Geddes
Primary Institution: Centro di Riferimento Oncologico, Aviano, Italy
Hypothesis
What are the survival rates and risk of second primary cancer in patients with classic Kaposi's sarcoma?
Conclusion
Patients with classic Kaposi's sarcoma have a median survival of 9.4 years, which is similar to the general population, and the risk of second primary cancers is not significantly different from what is expected.
Supporting Evidence
- One-year survival rate was 92%, five-year was 69%, and ten-year was 46%.
- Median survival was 9.4 years, similar to the general population.
- Eleven second primary cancers were reported, which is not different from the expected number.
Takeaway
People with classic Kaposi's sarcoma usually live a long time, and they don't get more other cancers than expected.
Methodology
The study assessed 204 patients with classic Kaposi's sarcoma identified from Italian cancer registries and followed them for survival and second cancer occurrences.
Potential Biases
Increased medical surveillance after KS diagnosis may have led to an overestimation of second primary cancers.
Limitations
The study lacked complete information on clinical and histological characteristics of KS patients and may have overestimated or underestimated the number of second primary cancers.
Participant Demographics
139 men (median age 70 years) and 65 women (median age 72 years).
Statistical Information
P-Value
0.006
Confidence Interval
95% CI = 0.70-1.68
Statistical Significance
p=0.006
Want to read the original?
Access the complete publication on the publisher's website